Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

6,271 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,271 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Early research (Phase 1)Study completedNCT00006485
What this trial is testing

Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00697632
What this trial is testing

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 180
Early research (Phase 1)Ended earlyNCT01200004
What this trial is testing

Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT01534598
What this trial is testing

FdCyd and THU for Advanced Solid Tumors

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 59
Early research (Phase 1)Study completedNCT01629758
What this trial is testing

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

Who this might be right for
Neoplasms by Site
Bristol-Myers Squibb 33
Testing effectiveness (Phase 2)UnknownNCT04282278
What this trial is testing

Study of Anti-PD-1 Antibody Multimodal Combination as First-line Treatment on Time Window of Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Hebei Medical University Fourth Hospital 180
Early research (Phase 1)Study completedNCT02640755
What this trial is testing

Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

Who this might be right for
Solid Malignancies
AstraZeneca 4
Testing effectiveness (Phase 2)Study completedNCT00425204
What this trial is testing

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Who this might be right for
Colorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more
Amgen 31
Testing effectiveness (Phase 2)UnknownNCT03389815
What this trial is testing

A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients

Who this might be right for
Advanced Solid Tumor, Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Ended earlyNCT03220347
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 139
Early research (Phase 1)Study completedNCT02723955
What this trial is testing

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Who this might be right for
Neoplasms
GlaxoSmithKline 829
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Early research (Phase 1)Looking for participantsNCT07182149
What this trial is testing

NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
HNSCCESCCEsophageal Adenocarcinoma+7 more
Normunity AccelCo, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT00084708
What this trial is testing

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 53
Early research (Phase 1)Ended earlyNCT04810208
What this trial is testing

Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor
Lidds AB 6
Early research (Phase 1)Study completedNCT01061749
What this trial is testing

Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Early research (Phase 1)Looking for participantsNCT06350006
What this trial is testing

SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor

Who this might be right for
CLDN18.2-positive Advanced Solid Tumor
Shanghai Hengrui Pharmaceutical Co., Ltd. 924
Next Page